We found that FSHD-like expression of DUX4 is associated with muscle eosinophilia and elevated levels of eotaxin and eosinophil peroxidase, which may serve as new muscle biomarkers for FSHD pathology. The gene discussed is CCL11; the disease is Increased total eosinophil count.